• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

荷兰东南部皮肤恶性黑色素瘤的最新生存估计及历史趋势

Up-to-date survival estimates and historical trends of cutaneous malignant melanoma in the south-east of The Netherlands.

作者信息

de Vries E, Houterman S, Janssen-Heijnen M L G, Nijsten T, van de Schans S A M, Eggermont A M M, Coebergh J W W

机构信息

Department of Public Health, Erasmus MC University Medical Centre Rotterdam, Rotterdam, The Netherlands.

出版信息

Ann Oncol. 2007 Jun;18(6):1110-6. doi: 10.1093/annonc/mdm087. Epub 2007 Apr 13.

DOI:10.1093/annonc/mdm087
PMID:17434898
Abstract

BACKGROUND

We present survival outcomes of patients registered in the Dutch population-based Eindhoven Cancer Registry (ECR).

PATIENTS AND METHODS

Data on patients diagnosed with a melanoma between 1980 and 2002 were obtained from the ECR. Data on vital status up to 1 January 2005 were obtained, up-to-date survival rates were calculated using period analysis. Multivariate analyses were carried out using Cox proportional hazards model.

RESULTS

Ten-year crude survival rates were 82% for women and 60% for men (P < 0.05). Thin melanomas (Breslow thickness <or= 2.0 mm) had 5-year crude survival rates >74%, for melanomas >4.0 mm these rates were <65% (P < 0.05). In the early 1980s, 5-year relative survival rates were 84% and 62% for young (<60 years) women and men, and 66% and 69%, respectively, for the elderly (aged 60+). In the period 2000-2002, these rates had improved to >90% for females and to >72% for males. Multivariate analyses showed increased hazard ratios with increasing age and Breslow thickness, being male, having a melanoma on the trunk or unknown sites and having a nodular melanoma.

CONCLUSIONS

Despite the absence of improvements in treatment options for melanoma, survival improved significantly, except for elderly males.

摘要

背景

我们呈现了荷兰基于人群的埃因霍温癌症登记处(ECR)登记患者的生存结果。

患者与方法

从ECR获取了1980年至2002年间诊断为黑色素瘤患者的数据。获取了截至2005年1月1日的生命状态数据,使用期间分析计算最新生存率。使用Cox比例风险模型进行多变量分析。

结果

女性的10年粗生存率为82%,男性为60%(P<0.05)。薄黑色素瘤(Breslow厚度≤2.0mm)的5年粗生存率>74%,对于厚度>4.0mm的黑色素瘤,这些比率<65%(P<0.05)。在20世纪80年代初,年轻(<60岁)女性和男性的5年相对生存率分别为84%和62%,老年人(60岁及以上)分别为66%和69%。在2000 - 2002年期间,女性的这些比率提高到>90%,男性提高到>72%。多变量分析显示,随着年龄、Breslow厚度增加、男性、躯干或不明部位有黑色素瘤以及有结节性黑色素瘤,风险比增加。

结论

尽管黑色素瘤的治疗选择没有改善,但除老年男性外,生存率显著提高。

相似文献

1
Up-to-date survival estimates and historical trends of cutaneous malignant melanoma in the south-east of The Netherlands.荷兰东南部皮肤恶性黑色素瘤的最新生存估计及历史趋势
Ann Oncol. 2007 Jun;18(6):1110-6. doi: 10.1093/annonc/mdm087. Epub 2007 Apr 13.
2
Trends of cutaneous melanoma in The Netherlands: increasing incidence rates among all Breslow thickness categories and rising mortality rates since 1989.荷兰皮肤黑色素瘤的趋势:所有 Breslow 厚度分类的发病率上升,自 1989 年以来死亡率上升。
Ann Oncol. 2012 Feb;23(2):524-30. doi: 10.1093/annonc/mdr128. Epub 2011 May 4.
3
Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia.澳大利亚昆士兰州人群中诊断为薄型黑色素瘤患者的 20 年生存率。
J Clin Oncol. 2012 May 1;30(13):1462-7. doi: 10.1200/JCO.2011.38.8561. Epub 2012 Mar 12.
4
Survival of cutaneous melanoma based on sex, age, and stage in the United States, 1992-2011.1992-2011 年美国基于性别、年龄和分期的皮肤黑色素瘤生存率。
Cancer Med. 2017 Oct;6(10):2203-2212. doi: 10.1002/cam4.1152. Epub 2017 Sep 6.
5
Conditional survival of malignant melanoma in The Netherlands: 1994-2008.荷兰恶性黑色素瘤的条件生存:1994-2008 年。
Eur J Cancer. 2014 Feb;50(3):602-10. doi: 10.1016/j.ejca.2013.10.019. Epub 2013 Nov 18.
6
Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors.1990 - 1999年瑞典侵袭性皮肤恶性黑色素瘤。一项基于人群的生存及预后因素前瞻性研究。
Cancer. 2004 Nov 1;101(9):2067-78. doi: 10.1002/cncr.20602.
7
Improved survival for melanoma in Northern Ireland: a comparison of two 5-year periods (1984-88 and 1994-98).北爱尔兰黑色素瘤患者生存率的提高:两个五年期(1984 - 1988年和1994 - 1998年)的比较
Br J Dermatol. 2004 Sep;151(3):587-93. doi: 10.1111/j.1365-2133.2004.06071.x.
8
The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.德国南部皮肤黑色素瘤的发病率和死亡率:1976年至2003年按解剖部位和病理特征划分的趋势
Cancer. 2006 Sep 15;107(6):1331-9. doi: 10.1002/cncr.22126.
9
Increasing time trends of thin melanomas in The Netherlands: What are the explanations of recent accelerations?荷兰薄型黑素瘤发病率呈上升趋势:最近加速的原因是什么?
Eur J Cancer. 2015 Dec;51(18):2833-41. doi: 10.1016/j.ejca.2015.09.008. Epub 2015 Nov 14.
10
Incidence trends and clinical-pathological characteristics of invasive cutaneous melanoma from 1980 to 2010 in the Canton of Zurich, Switzerland.1980年至2010年瑞士苏黎世州侵袭性皮肤黑色素瘤的发病趋势及临床病理特征
Melanoma Res. 2017 Apr;27(2):145-151. doi: 10.1097/CMR.0000000000000312.

引用本文的文献

1
Thickness of melanocytes in giant congenital melanocytic nevus for complete surgical excision: clinicopathological evaluation of 117 lesions according to the area and size.巨先天性黑色素细胞痣完全切除的黑色素细胞厚度:根据面积和大小对 117 个病变的临床病理评估。
BMC Surg. 2024 Mar 15;24(1):90. doi: 10.1186/s12893-024-02362-x.
2
Cutaneous melanoma incidence, mortality, and survival in Manizales, Colombia: a population-based study.哥伦比亚马尼萨莱斯的皮肤黑色素瘤发病率、死亡率和生存率:一项基于人群的研究。
J Int Med Res. 2022 Jun;50(6):3000605221106706. doi: 10.1177/03000605221106706.
3
Immunomodulatory Effects of BRAF, MEK, and CDK4/6 Inhibitors: Implications for Combining Targeted Therapy and Immune Checkpoint Blockade for the Treatment of Melanoma.
BRAF、MEK 和 CDK4/6 抑制剂的免疫调节作用:对联合靶向治疗和免疫检查点阻断治疗黑色素瘤的意义。
Front Immunol. 2021 May 7;12:661737. doi: 10.3389/fimmu.2021.661737. eCollection 2021.
4
The lncRNA SLNCR Recruits the Androgen Receptor to EGR1-Bound Genes in Melanoma and Inhibits Expression of Tumor Suppressor p21.长链非编码 RNA SLNCR 在黑色素瘤中招募雄激素受体到 EGR1 结合基因,并抑制肿瘤抑制因子 p21 的表达。
Cell Rep. 2019 May 21;27(8):2493-2507.e4. doi: 10.1016/j.celrep.2019.04.101.
5
Identification of gene expression levels in primary melanoma associated with clinically meaningful characteristics.鉴定原发性黑色素瘤中与具有临床意义的特征相关的基因表达水平。
Melanoma Res. 2018 Oct;28(5):380-389. doi: 10.1097/CMR.0000000000000473.
6
Psychosocial consequences of skin cancer screening.皮肤癌筛查的心理社会后果。
Prev Med Rep. 2018 Apr 17;10:310-316. doi: 10.1016/j.pmedr.2018.04.011. eCollection 2018 Jun.
7
Tumour stage distribution and survival of malignant melanoma in Germany 2002-2011.2002 - 2011年德国恶性黑色素瘤的肿瘤分期分布与生存率
BMC Cancer. 2016 Dec 5;16(1):936. doi: 10.1186/s12885-016-2963-0.
8
The lncRNA SLNCR1 Mediates Melanoma Invasion through a Conserved SRA1-like Region.长链非编码RNA SLNCR1通过一个保守的类SRA1区域介导黑色素瘤侵袭。
Cell Rep. 2016 May 31;15(9):2025-37. doi: 10.1016/j.celrep.2016.04.018. Epub 2016 May 19.
9
Statin use and its effect on all-cause mortality of melanoma patients: a population-based Dutch cohort study.他汀类药物的使用及其对黑色素瘤患者全因死亡率的影响:一项基于人群的荷兰队列研究。
Cancer Med. 2014 Oct;3(5):1284-93. doi: 10.1002/cam4.285. Epub 2014 Jun 17.
10
Streamlining cutaneous melanomas in young women of the Belgian Mosan region.简化比利时摩泽尔地区年轻女性皮肤黑色素瘤的治疗流程
Biomed Res Int. 2014;2014:320767. doi: 10.1155/2014/320767. Epub 2014 Feb 25.